TSWM
LJPC

Tyler-Stone Wealth Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Tyler-Stone Wealth Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-500
Closed -$2K – 924
2022
Q2 		$2K Hold
500
– – ﹤0.01% 786
2022
Q1 		$2K Hold
500
– – ﹤0.01% 763
2021
Q4 		$2K Buy
+500
New +$2.08K ﹤0.01% 827

Tyler-Stone Wealth Management's LJPC Position: Q3 2022 in Review

Tyler-Stone Wealth Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 500 shares — an estimated $2K sold.

Tyler-Stone Wealth Management first reported a position in LJPC in Q4 2021 and held it in 3 quarters. The position peaked at $2K in Q2 2022. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.

  • Tyler-Stone Wealth Management reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 500 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $2K.
  • Tyler-Stone Wealth Management first reported a position in La Jolla Pharmaceutical Company in Q4 2021 and held it in 3 quarters.
  • Tyler-Stone Wealth Management's La Jolla Pharmaceutical Company position peaked at $2K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.

Based on Tyler-Stone Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.